[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.172.195.49. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 13, 1981

Management of Asymptomatic Hyperuricemia

Author Affiliations

From the Renal Section, Department of Medicine, Veterans Administration Medical Center and Baylor College of Medicine, Houston.; Dr Duffy is a fellow in nephrology of Baylor College of Medicine. Dr Knight is a research associate of the Veterans Administration.

JAMA. 1981;246(19):2215-2216. doi:10.1001/jama.1981.03320190063034
Abstract

Although the incidence of gout, renal stones, or both is increased in patients with hyperuricemia, there is no evidence that long-term therapy offers any substantial long-term benefits. Recent data also suggest that no clear relationship exists between hyperuricemia and the development of interstitial nephritis (so-called urate nephropathy). Finally, the relationship between elevations in the serum concentration of uric acid and the risk of developing cardiovascular disease remains undefined. It is recommended that, in a patient with asymptomatic hyperuricemia, a conservative approach be taken and hypouricemic therapy not be instituted as a matter of routine.

(JAMA 1981;246:2215-2216)

×